EconPapers    
Economics at your fingertips  
 

Worldwide public policies for celiac disease: are patients well assisted?

Ana Luísa Falcomer (), Bruna Araújo Luchine, Hanna Ramalho Gadelha, José Roberto Szelmenczi, Eduardo Yoshio Nakano, Priscila Farage and Renata Puppin Zandonadi
Additional contact information
Ana Luísa Falcomer: University of Brasilia
Bruna Araújo Luchine: University of Brasilia
Hanna Ramalho Gadelha: University of Brasilia
José Roberto Szelmenczi: University of Brasilia
Eduardo Yoshio Nakano: University of Brasilia
Priscila Farage: Federal University of Goiás (UFG)
Renata Puppin Zandonadi: University of Brasilia

International Journal of Public Health, 2020, vol. 65, issue 6, No 31, 937-945

Abstract: Abstract Objectives To evaluate public policies (PP) to celiac disease (CD) patients and classify countries regarding the level of assistance provided by the Public Policies for Celiac Disease Score. Methods Countries were scored from 0 to 6 according to the existence of PP regarding industrial food and meal regulations, health service support, food allowance/financial incentive, gluten-free (GF) food certification, and CD associations. Subsequently, countries were allocated to continents. In total, 192 countries are registered as members of the World Health Organization. Results The European continent (score 3.63) is the most advanced in CD patient care, followed by South America (2.86), North America (1.05), Asia (0.53), Oceania (0.5), and Africa (0.27). Industrial food regulations were the most frequent PP (40.6%). 15.6% of the countries display regulations for meals; 13.5% have health service support; 13.5% have policies of food allowance/financial incentive; 19.3% have GF certification; and 34.4% have celiac associations. Conclusions Policies regarding GF meals and food safety certification, health service support, and financial incentives need improvement to ensure correct treatment and reduce the diseases’ financial burden for celiac patients and governments.

Keywords: Public health; Celiac disease; Legislation; Regulation (search for similar items in EconPapers)
Date: 2020
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s00038-020-01451-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:ijphth:v:65:y:2020:i:6:d:10.1007_s00038-020-01451-x

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/00038

DOI: 10.1007/s00038-020-01451-x

Access Statistics for this article

International Journal of Public Health is currently edited by Thomas Kohlmann, Nino Künzli and Andrea Madarasova Geckova

More articles in International Journal of Public Health from Springer, Swiss School of Public Health (SSPH+)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-20
Handle: RePEc:spr:ijphth:v:65:y:2020:i:6:d:10.1007_s00038-020-01451-x